Spero Therapeutics Competitors and Similar CompaniesClear all
Spero Therapeutics's competitors and similar companies include EnClear Therapies, MicrofluidX, CHF Solutions and Respicardia.
 Spero Therapeutics Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections. |  EnClear Therapies EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases. |  CHF Solutions CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients. |  Respicardia Respicardia develops implantable therapies to improve respiratory and cardiovascular health. | ||
Founding Date | Founding Date 2013 | Founding Date 2018 | Founding Date 2018 | Founding Date 1999 | Founding Date 2006 |
Type | Type Public | Type Private | Type Private | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Newburyport, US HQ | Locations HQ | Locations Eden Prairie, US HQ | Locations Hopkins, US HQ |
Employees | Employees 5739% increase | Employees 11 | Employees 405% decrease | Employees 6620% increase | Employees 94 |
Valuation ($) | Valuation ($) 70.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 34.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $66.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income $8.6m (FY, 2025) | Net income N/A | Net income N/A | Net income ($17.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (over 6 years ago) | Latest funding round $ 1.7m (about 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 121.5m | Total funding raised $ 12m | Total funding raised $ 1.7m | Total funding raised $ 9m | Total funding raised $ 149.1m |
For sources of this data, please see the company profile
View Company Profiles
EnClear Therapies
HQ
Newburyport, US
Employees
11
EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.
View company
MicrofluidX
HQ
Employees
40↓ 5% decrease
MicrofluidX is a company that develops cell bioprocessing technology.
View companyCHF Solutions
HQ
Eden Prairie, US
Employees
66↑ 20% increase
CHF Solutions (formerly Sunshine Heart) is a biotech company focused on developing an innovative cardiac therapy to treat heart patients.
View companyRespicardia
HQ
Hopkins, US
Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
View company